All companies
Visit website
ONUS IV BY YOUR BEST DAYS, INC.
OperatingYour Best Days, Inc.
Healthcare · Founded 2024
Onus iV therapy + longevity
Post-money valuation ⓘ
$8.2M
As of Feb 2025 · from Reg CF Offering (2024) · pre-money + amount raised, not a traded price
Total raised
$178,597
Across 1 round since 2024
Latest share price
$1.00
Reg CF Offering (2024) offering price
Financials
FY2022–FY2024 · from SEC filings · hover any figure for its source$2.7M
$82K
2022
$2.8M
−$373K
2023
$2.9M
−$245K
2024
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2022
FY2023
FY2024
Income statement
Revenue
$2,730,702
$2,840,002
$2,907,710
Cost of goods sold
$719,573
$624,722
$625,342
Gross margin
74%
78%
78%
Net income
$81,903
-$372,852
-$244,629
Taxes paid
$0
$0
$0
Balance sheet
Cash
$233,397
$101,774
$31,049
Accounts receivable
$0
$0
$0
Total assets
$1,341,811
$1,344,379
$826,755
Short-term debt
$0
$539,064
$495,747
Long-term debt
$309,261
$878,315
$637,695
Total liabilities
$309,261
$1,417,379
$1,133,442
Other
Headcount
—
3
3
Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didn’t state one. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Valuation over rounds
Post-money = pre-money + amount raised · caps marked$8.2M
post-money
Reg CF Offering (2024)
A dashed amber step is a SAFE/note valuation cap — a conversion ceiling agreed for that instrument, not a priced valuation of the company. Steps are not comparable across bases.
Fundraising history
Raised $178.6K / $1.2MInvestors 53Post-money $8.2M
Reg CF annual-report compliance
Not requiredFewer than 300 holders of record
Filed 1 of 2 annual reports (FY2024–FY2025)
53 investors
holder-count proxy
Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.
SEC filings
View all 9 filings on EDGARSource: ManualCIK 0002042791Share price $1.00
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.